Clinical Trials on Restenosis or Adverse Cardiovascular Event

Total 7571 results

Helse Stavanger HF

Completed

Endothelial Function and Heart Rate Variability After Stenting (FUNKIS)

Restenosis or Adverse Cardiovascular Event

Norway
Lin Zhao

Recruiting

Effect of Evolocumab on Chronic Total Occlusions (EVOLO-CTO)

In-stent Restenosis | Major Adverse Cardiovascular Events

China
University of Pittsburgh
RAND

Completed

Enhancing the Detection and Management of Adverse Drug Events in Nursing Homes

Adverse Drug Events

United States
US Department of Veterans Affairs

Completed

Patient Profiling and Provider Feedback to Reduce Adverse Drug Events

Adverse Drug Events

United States
Westview Physician Collaborative

Completed

Eliminating Risk of Preventable Adverse Drug Events at the Hospital-community Interface of Care (CMR)

Adverse Drug Events

Canada
Ottawa Hospital Research Institute
McGill University; Canadian Institutes of Health Research (CIHR)

Completed

Information Systems-enabled Outreach Program for Adverse Drug Events (ISTOP-ADE)

Adverse Drug Events

Canada
Intermountain Health Care, Inc.

Completed

Response to Medication Registry

Adverse Drug Events

United States
Cedars-Sinai Medical Center
National Institutes of Health (NIH); National Institute on Aging (NIA)

Completed

Pharmacists and Pharmacy Technicians to Improve Admission Medication History Accuracy

Adverse Drug Events
University of Massachusetts, Worcester
Agency for Healthcare Research and Quality (AHRQ); Baycrest Centre for Geriatric...

Withdrawn

Reducing Adverse Drug Events in the Nursing Home

Adverse Drug Events
Indiana University
Brigham and Women's Hospital

Completed

Improving Safety by Basic Computerizing Outpatient Prescribing

Adverse Drug Events

United States
Sultan Qaboos University

Completed

Impact of Medication Reconciliation Intervention on the Rate of Preventable Adverse Drug Events (ADEs) and Healthcare Utilization

Adverse Drug Events
VA Office of Research and Development

Completed

Implementation of Real-time ADE Surveillance and Decision Support (VA ADE)

Adverse Drug Events

United States
University of Massachusetts, Worcester
Agency for Healthcare Research and Quality (AHRQ); Qualidigm

Completed

Enhancing the Safety of Warfarin in Nursing Homes

Adverse Drug Events (ADEs)

United States
McGill University
Canadian Institutes of Health Research (CIHR)

Completed

Using Novel Canadian Resources to Improve Medication Reconciliation at Discharge

Adverse Drug Events | Medication Reconciliation

Canada
Brigham and Women's Hospital
University of Chicago; University of Wisconsin, Madison; University of California... and other collaborators

Completed

Multi-Center Medication Reconciliation Quality Improvement Study (MARQUIS)

Medication Administered in Error | Adverse Drug Events

United States
Brigham and Women's Hospital

Unknown

Ambulatory Medication Reconciliation Following Hospital Discharge

Medication Administered in Error | Adverse Drug Events

United States
University Hospital, Montpellier

Completed

Drug-Related Problems : Focus on Age and Diabetes (DRP-AD)

Adverse Drug Events

France
Xuanwu Hospital, Beijing

Unknown

Safety and Efficacy of Distal Embolic Protection Device in Vertebral Artery Origin Stenting

Adverse Event

China
Nantes University Hospital
Université de Nantes

Not yet recruiting

Patient Safety Incidents in Coordinated Primary Care Teams: a Multi-method Study (EVIDENS-Prim)

Adverse Event
Université du Québec à Trois-Rivières

Completed

Adverse Events Associated With Manual Therapies in Children

Adverse Event

Canada
Institut Mutualiste Montsouris

Recruiting

Fast-Track Cardiovascular Assessment for Suspicion of Cardiovascular Events on Immunecheckpoint Inhibitors (FAST-TRACK)

Cancer | Cardiovascular Complication | Immune Checkpoint Inhibitor | Immune-related Adverse Event

France
Hospices Civils de Lyon

Unknown

Impact on the Adverse Event (AE) Incidence of Two Types of Experience Feedback on AE Analyzed During Local Morbidity Mortality Reviews (RMM Simulation)

Hospital Adverse Event

France
Universidad Miguel Hernandez de Elche
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la...

Active, not recruiting

Gender Bias in the Overuse Studies Conducting in Primary Care (OVERGEND)

Severe Adverse Event

Spain
Lucie Heinzerling

Recruiting

Treatment of Immune-related Adverse Events Refractory to Standard Therapy and Associated Changes in Immunophenotype (PRIA)

Immune-related Adverse Event

Germany
Chang Gung Memorial Hospital
Ministry of Science and Technology, Taiwan

Recruiting

Hyperpolarized 13C-MRI and Metabolomics for Immune-related Adverse Events (DNP_irAE)

Immune-related Adverse Event

Taiwan
University of Rochester
Agency for Healthcare Research and Quality (AHRQ)

Completed

Emergency Pharmacist Safety Study

Adverse Drug Event, Potential Adverse Drug Event, and Quality Measures

United States
AstraZeneca

Completed

Observational Prospective Study OPTIMA II - Follow-up (OPTIMAII)

Major Adverse Cardiovascular and Cerebrovascular Events (MACCE)

Russian Federation
Duke University

Enrolling by invitation

Immune-Related Adverse Events and Associated Biomarkers in Patients Receiving Cancer Immunotherapy (IMBARC)

Cancer | Immune-related Adverse Event

United States
General Hospital of Ningxia Medical University

Completed

Prophylactic Norepinephrine Infusion Combined With Colloid Coloading for Postspinal Anesthesia Hypotension

Adverse Event

China
Medstar Health Research Institute

Completed

Registry Experience at the Washington Hospital Center With Drug Eluting Stents - Synergy

Incidence of Major Adverse Cardiac Events

United States
Universitair Ziekenhuis Brussel

Recruiting

Food Intervention to Reduce Immunotherapy toXicity (FORX01)

Dietary Habits | Immune-related Adverse Event

Belgium
GlaxoSmithKline

Completed

CV Events in Emetogenic Chemotherapy

Vomiting | Cardiovascular Event | Arterial Thromboembolic Event
University of Alberta

Completed

Comparison of Active vs. Passive Surveillance to Collect Adverse Events

Adverse Events

Canada
Irrimax Corporation

Completed

Retrospective Independent Safety Review of Closed Irrisept Study

Adverse Events

United States
CHU de Reims

Completed

Elaboration of a Prioritization Score for Pharmaceutical Interviews in Patients Treated With Oral Anticoagulants

Thromboembolic Event

France
Emory University
National Association of Orthopaedic Nurses

Completed

App Reminder on ASA Adherence

Thromboembolic Event

United States
Northwestern University
University of Michigan; The University of Texas Health Science Center at San... and other collaborators

Completed

Redesigning Systems to Improve Quality for Hospitalized Patients (RESET)

Interdisciplinary Communication | Adverse Event | Interprofessional Relations | Interpersonal Relations

United States
Brigham and Women's Hospital
Crico

Completed

PREventing Adverse Events Post-Discharge Through Proactive Identification, Multidisciplinary Communication, and Technology (PREDICT)

Adverse Event | Transitions of Care | General Medicine | Discharge Checklist

United States
University of Sao Paulo General Hospital

Completed

Adverse Events During Physiotherapy at Intensive Care Unit In Patients Undergoing Cardiac Surgery (Adephysio)

Cardiac Surgery | Physiotherapy | Adverse Event | Intensive Care Units | Postoperative
Zhong Wang
Shanxi Zhendong Pharmacy Co., Ltd

Recruiting

Post-marketing Safety Surveillance of Qizhi Tongluo Capsules:a Registry Study.

Adverse Drug Events | Adverse Drug Reactions | Severe Adverse Events | Safety Surveillance | Severe Adverse Reactions

China
AstraZeneca

Completed

Study to Compare the Bioavailability of ABT-335 and Rosuvastatin From ABT-143 Relative to That From the Co-administration of ABT-335 and Rosuvastatin Calcium

Adverse Events | Pharmacokinetic

United States
Zhong Wang
Shanxi Zhendong pharmaceutical Co. LTD.

Completed

Post-marketing Safety Surveillance of Compound Kuh-seng Injection: a Registry Study

Adverse Drug Events | Adverse Drug Reactions | Severe Adverse Events | Safety Surveillance | Severe Adverse Reactions

China
Atrial Fibrillation Network

Completed

Prospective Registration and Assessment of Serious Adverse Events Within the AFNET (AFNET A7)

Atrial Fibrillation | Assessment of Serious Advers Events | Thromboembolic and Bleeding Complications | Complications of Antiarrhythmic Drugs or Invasive Procedures | Assessment by a Critical Event Committee

Germany
Sichuan Provincial People's Hospital

Recruiting

Risk Factors and Risk Grading Prediction of Perioperative Respiratory Adverse Events in Children

Perioperative Respiratory Adverse Events

China
AstraZeneca

Completed

Study to Compare the Bioavailability of ABT-335 and Rosuvastatin From ABT-143 Capsules Relative to That From Co-administration of ABT-335 and Rosuvastatin for the 5/45mg Dosage Form.

Adverse Events | Pharmacokinetic Variables

United States
Centre Hospitalier Universitaire, Amiens
Central Hospital Saint Quentin

Recruiting

Identification of Predictive Biomarkers for Immune-Related Adverse Events (irAEs) in Patients Undergoing Immune CheckPoint Inhibitors (ICPI) Treatment (Ibe2i-TIPCI)

Immunotherapy | Immune Checkpoint Inhibitors | Immune-related Adverse Event | Predictive Biomarkers

France
Bamrasnaradura Infectious Diseases Institute

Completed

Nevirapine Levels and Fluconazole

Adverse Event | Nevirapine | Fluconazole
Insel Gruppe AG, University Hospital Bern
The Hospital for Sick Children; Children's Hospital of Philadelphia; Charite... and other collaborators

Recruiting

CRICKET: Critical Events in Anaesthetised Kids Undergoing Tracheal Intubation (CRICKET)

Intubation Complication | Adverse Events

United States, Australia, Canada, Germany, Switzerland
Pierre Van Damme

Completed

A Study to Assess the Acceptability and Usability of a New Device for Intradermal Vaccination

Pain | Vaccination Adverse Event

Belgium
University of British Columbia
Canadian Institutes of Health Research (CIHR); Vancouver Coastal Health; Ministry...

Not yet recruiting

Evaluating ActionADE in Reducing Adverse Drug Reactions

Adverse Drug Event | Adverse Drug Reaction

Clinical Trials on Restenosis or Adverse Cardiovascular Event

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Uzbekistan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations